Skip to main content

Publications

featured publications
  • Extremely low arylsulfatase A enzyme activity does not necessarily cause symptoms: A long-term follow-up and review of the literature.

    JIMD reports

    Authors: Lucia Laugwitz, Vidiyaah Santhanakumaran, Mareike Spieker, Judith Boehringer, Benjamin Bender, Volkmar Gieselmann, Stefanie Beck-Woedl, Gernot Bruchelt, Klaus Harzer, Ingeborg Kraegeloh-Mann, Samuel Groeschel

    View this publication
  • JAK1/2 inhibitor but not IL-4 receptor alpha antibody suppresses allergen-mediated activation of human basophils in vitro.

    Allergy

    Authors: Wenming Peng, Said Benfadal, Chunfeng Yu, Jörg Wenzel, Johannes Oldenburg, Natalija Novak

    View this publication
  • Fight INflammation to Improve outcome after aneurysmal Subarachnoid HEmorRhage (FINISHER) trial: Study protocol for a randomized controlled trial.

    International journal of stroke : official journal of the International Stroke Society

    Authors: Erdem Güresir, Tim Lampmann, Sylvia Bele, Marcus Czabanka, Patrick Czorlich, Jens Gempt, Roland Goldbrunner, Helene Hurth, Elvis Hermann, Ramazan Jabbarli, Marius Krauthausen, Ralph König, Dirk Lindner, Vesna Malinova, Jürgen Meixensberger, Dorothee Mielke, Robert Németh, Marvin Darkwah Oppong, Andrej Pala, Vincent Prinz, Ali Rashidi, Constantin Roder, Ibrahim Erol Sandalcioglu, Thomas Sauvigny, Karl-Michael Schebesch, Marco Timmer, Peter Vajkoczy, Lars Wessels, Florian Wild, Christoph Wilhelm, Maria Wostrack, Hartmut Vatter, Christoph Coch

    View this publication
  • Percutaneous trans-axilla transcatheter aortic valve replacement.

    Heart and vessels

    Authors: Atsushi Sugiura, Mitsumasa Sudo, Baravan Al-Kassou, Jasmin Shamekhi, Miriam Silaschi, Nihal Wilde, Alexander Sedaghat, Ulrich Marc Becher, Marcel Weber, Jan-Malte Sinning, Eberhard Grube, Georg Nickenig, Efstratios I Charitos, Sebastian Zimmer

    View this publication
  • The neuropeptide VIP potentiates intestinal innate type 2 and type 3 immunity in response to feeding.

    Mucosal immunology

    Authors: Maud Pascal, Alexander Kazakov, Grégoire Chevalier, Lola Dubrule, Julie Deyrat, Alice Dupin, Soham Saha, Ferdinand Jagot, Kurt Sailor, Sophie Dulauroy, Carine Moigneu, Yasmine Belkaid, Gabriel Lepousez, Pierre-Marie Lledo, Christoph Wilhelm, Gérard Eberl

    View this publication
  • Aneurysmal Subarachnoid Hemorrhage during the Shutdown for COVID-19.

    Journal of clinical medicine

    Authors: Erdem Güresir, Ingo Gräff, Matthias Seidel, Hartmut Bauer, Christoph Coch, Christian Diepenseifen, Christian Dohmen, Susanne Engels, Alexis Hadjiathanasiou, Ulrich Heister, Inge Heyer, Tim Lampmann, Sebastian Paus, Gabor Petzold, Dieter Pöhlau, Christian Putensen, Matthias Schneider, Patrick Schuss, Jochen Textor, Markus Velten, Johannes Wach, Thomas Welchowski, Hartmut Vatter

    View this publication
  • DNA Methylation and mRNA Expression of OX40 (TNFRSF4) and GITR (TNFRSF18, AITR) in Head and Neck Squamous Cell Carcinoma Correlates With HPV Status, Mutational Load, an Interferon-γ Signature, Signatures of Immune Infiltrates, and Survival.

    Journal of immunotherapy (Hagerstown, Md. : 1997)

    Authors: Sophia M Loick, Anne Fröhlich, Jennis Gabrielpillai, Alina Franzen, Timo J Vogt, Jörn Dietrich, Constanze Wiek, Kathrin Scheckenbach, Sebastian Strieth, Jennifer Landsberg, Dimo Dietrich

    View this publication
  • Impaired activated protein C response rates indicate a thrombophilic phenotype in inherited thrombophilia.

    Haematologica

    Authors: Sara Reda, Nadine Schwarz, Jens Muller, Johannes Oldenburg, Bernd Potzsch, Heiko Ruhl

    View this publication
  • Comparison of Empiric Antibiotic Escalation Therapy with Vancomycin (VAN) versus Linezolid (LIN) in Patients with Febrile Neutropenia.

    Mediterranean journal of hematology and infectious diseases

    Authors: Karin Mayer, Nicolaus Hegge, Ernst Molitor, Peter Brossart, Corinna Hahn-Ast

    View this publication
  • Clofarabine increases the eradication of minimal residual disease of primary B-precursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome. Results from the randomized clinical trial 08-09 of the Cooperative …

    Haematologica

    Authors: Gabriele Escherich, Udo Zur Stadt, Arndt Borkhardt, Dagmar Dilloo, Jörg Faber, Tobias Feuchtinger, Thomas Imschweiler, Norbert Jorch, Arnulf Pekrun, Irene Schmid, Franziska Schramm, Michael Spohn, Martin Zimmermann, Martin A Horstmann

    View this publication